What MyoKardia, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Agarwal Sunil | Director | Nov 17 | Tender Offer · U | −4,100 | — | — | 0 |
| Bauer Jake | Chief Business Officer | Nov 17 | Tender Offer · U | −90,209 | — | — | 0 |
| Fairey William | EVP, Chief Commercial Officer | Nov 17 | Tender Offer · U | −42,199 | — | — | 0 |
| Harris Taylor C. | Chief Financial Officer | Nov 17 | Tender Offer · U | −42,559 | — | — | 0 |
| Meeker David P | Director | Nov 17 | Tender Offer · U | −4,100 | — | — | 0 |
| Popovits Kimberly J | Director | Nov 17 | Tender Offer · U | −4,100 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −53,087 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −53,087 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −53,087 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −10,000 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −7,000 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −300,000 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −129,407 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Nov 17 | Tender Offer · U | −141,405 | — | — | 0 |
| Yarno Wendy L | Director | Nov 17 | Tender Offer · U | −5,508 | — | — | 0 |
| Cranston Mary B | Director | Nov 17 | Tender Offer · U | −4,100 | — | — | 0 |
| Waynick Denelle J | Chief Legal Officer | Nov 17 | Tender Offer · U | −25,000 | — | — | 0 |
| Perry Mark L | Director | Nov 17 | Tender Offer · U | −29,508 | — | — | 0 |
| McDowell Robert Scott | Chief Scientific Officer | Nov 17 | Tender Offer · U | −36,616 | — | — | 0 |
| Gianakakos Anastasios | President and CEO | Jul 02 | Open-market sale · S | −3,224 | $94.22 | −$304K | 19,122 |
Loading...
